Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Torrent Pharmaceuticals Ltd

+ Add to Watchlist

TRP:IN

1,138.25 INR 3.90 0.34%

As of 07:06:29 ET on 03/27/2015.

Snapshot for Torrent Pharmaceuticals Ltd (TRP)

Open: 1,148.80 Day's Range: 1,120.10 - 1,153.00 Volume: 30,124
Previous Close: 1,134.35 52wk Range: 520.25 - 1,231.70 1-Yr Rtn: +117.61%

Stock Chart for TRP

No chart data available.
  • TRP:IN 1,138.25
  • 1D
  • 1M
  • 1Y
1,134.35
Interactive TRP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TRP

Current P/E Ratio (ttm) 29.0148
Estimated P/E(03/2015) 25.6345
Relative P/E vs. SENSEX 1.5215
Earnings Per Share (INR) (ttm) 39.2300
Est. EPS (INR) (03/2015) 44.4030
Est. PEG Ratio -
Market Cap (M INR) 192,608.34
Shares Outstanding (M) 169.21
30 Day Average Volume 84,630
Price/Book (mrq) 10.1248
Price/Sale (ttm) 4.7721
Dividend Indicated Gross Yield 0.88%
Cash Dividend (INR) 5.0000
Dividend Ex-Date 02/02/2015
5 Year Dividend Growth 37.97%
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TRP

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for TRP

Torrent Pharmaceuticals Ltd. manufactures bulk drugs and pharmaceutical formulations. The Company's formulations include cardio-vascular, psychotropic and anti-biotic drugs while its bulk drugs include atenolol, ciprofloxacin and norfloxacin. Torrent Pharmaceuticals has wholly owned subsidiaries in several regulated and less regulated international markets.

Samir Uttamlal MehtaChairmanAshok ModiExec VP/CFO
Mahesh D AgrawalVP:Legal/Secy/Compliance OfcrChaitanya DuttDir:Research & Development
More Company Profile & Key Executives for TRP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil